"Silicon intelligence and ReBio biology sign a strategic cooperation agreement"

On May 12th, YingSili Intelligence announced that the company has signed a strategic cooperation agreement with Ribobio. Building upon the existing collaboration in laboratory automation, intelligence, and scale based on YingSili Intelligence's LifeStar 2, the two parties will further integrate YingSili Intelligence's Pharma.AI platform end-to-end R&D capabilities with Ribobio's deep expertise in small nucleic acid drug development to enhance the efficiency of small nucleic acid drug research and development.